Wednesday, March 23, 2016
ImpediMed Raises $56.8M In Private Placement
ImpediMed, a developer of medical devices used to measure, monitor, and manage fluid status in patients, said Tuesday that it has raised $56.8M in a private placement. The company--which is based in Australia, but has its U.S. headquarters in Carlsbad--said it raised A$75.1M in its private placement with institutional investors. The funding was managed by Canaccord Genuity (Australia) Limited. The company's medical technology is used in treatment of chronic heart failure.
Get More SocalTech Data
Try our two week free trial to find new tech customers, find high tech startups and jobs, find venture funding, and more!Learn More